Single Ascending and Multiple Ascending Dose Trial Demonstrated AJA001 to be Safe and Well-tolerated, with Formulation Optimized for ASD Presentation at the 63rd Annual Meeting of the American College of Neuropsychopharmacology LITTLETON, Colo., Dec. 12, 2024 /PRNewswire/ — DeFloria, a…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
If you could design an oral treatment that limits appetite and mimics some effects of physical activity, you might call it exercise in a pill. Now a company is releasing early results for a compound […]
Most of us are all too familiar with the consequences of a poor night’s sleep – be it interrupted sleep or simply too little of it. If you’re a parent with kids at home, it […]
Robert Huizinga → According to an SEC filing, Aurinia’s EVP of research Robert Huizinga and CMO Neil Solomons are both walking away by Halloween, and while no explanations are given, details of their severance packages […]
Copyright © 2026 Biotech Networks
